FDA approves Roche's cancer immunotherapy TECENTRIQ (atezolizumab) for people with a specific type of metastatic lung cancer
|
19 October 2016 |
FDA grants Breakthrough Therapy Designation for Roche's Alecensa (alectinib) for first-line treatment of people with ALK-positive NSCLC
|
05 October 2016 |
Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Index for the eighth year running
|
09 September 2016 |
Roche delivers continued growth in the first half of 2016
|
25 July 2016 |
Roche employees raise funds for vulnerable children in over 90 communities around the world
|
17 June 2016 |
Roche reports solid sales growth in the first quarter of 2016
|
19 April 2016 |
FDA grants priority review for Roche's cancer immunotherapy atezolizumab in specific type of lung cancer
|
15 April 2016 |
FDA grants Roche's Cancer Immunotherapy Atezolizumab priority review for advanced bladder cancer
|
15 March 2016 |
U.S. FDA grants Breakthrough Therapy Designation for Roche's investigational medicine ocrelizumab in primary progressive multiple sclerosis
|
17 February 2016 |
Roche and Upsher-Smith announce license agreement to develop novel VAP-1 inhibitor
|
02 December 2015 |
Roche receives EU approval of Cotellic for use in combination with Zelboraf in advanced melanoma
|
25 November 2015 |
Roche to restructure its manufacturing network for small molecules
|
18 November 2015 |
Roche delivers strong sales growth in the first nine months of 2015
|
26 October 2015 |
Roche's ocrelizumab first investigational medicine to show positive pivotal study results in both relapsing and primary progressive forms of multiple sclerosis
|
09 October 2015 |
New Roche Esbriet data show clinical benefits of continued and long-term treatment in patients with idiopathic pulmonary fibrosis (IPF)
|
01 October 2015 |
For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
|
14 September 2015 |
"Roche Continents" fosters innovation in science and art
|
11 August 2015 |
Roche employees unite to raise funds for children in need
|
16 June 2015 |
Roche reports strong sales growth in the first quarter of 2015
|
23 April 2015 |
Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics
|
11 February 2015 |